We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRONU
801
DELISTED
Frontier Acquisition Corp. Units
FRONU
$988K ﹤0.01%
100,000
SSAAU
802
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
$988K ﹤0.01%
100,000
BLUA.U
803
DELISTED
BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary shares
BLUA.U
$987K ﹤0.01%
100,000
OEPWU
804
DELISTED
One Equity Partners Open Water I Corp. Unit
OEPWU
$987K ﹤0.01%
100,000
PLMIU
805
DELISTED
Plum Acquisition Corp. I Units
PLMIU
$985K ﹤0.01%
100,000
UL icon
806
Unilever
UL
$144B
$981K ﹤0.01%
+16,217
New +$963K
PSPC.U
807
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
$976K ﹤0.01%
92,081
EDR
808
DELISTED
Endeavor Group Holdings, Inc.
EDR
$971K ﹤0.01%
+27,831
New +$787K
TRGP icon
809
Targa Resources
TRGP
$56.2B
$966K ﹤0.01%
18,490
CP icon
810
Canadian Pacific Kansas City
CP
$81.4B
$923K ﹤0.01%
+12,825
New +$937K
NXPI icon
811
NXP Semiconductors
NXPI
$65.4B
$922K ﹤0.01%
+4,046
New +$860K
POOL icon
812
Pool Corp
POOL
$7B
$894K ﹤0.01%
1,579
VCYT icon
813
Veracyte
VCYT
$4.44B
$884K ﹤0.01%
+21,475
New +$949K
INFU icon
814
InfuSystem Holdings
INFU
$200M
$862K ﹤0.01%
+50,628
New +$803K
SHG icon
815
Shinhan Financial Group
SHG
$32.8B
$843K ﹤0.01%
+27,263
New +$875K
ITMR
816
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$835K ﹤0.01%
26,910
-23,015
-46% -$702K
MELI icon
817
Mercado Libre
MELI
$94.4B
$828K ﹤0.01%
614
-2,635
-81% -$3.7M
ABNB icon
818
Airbnb
ABNB
$90.9B
$806K ﹤0.01%
4,840
ALB icon
819
Albemarle
ALB
$13.3B
$797K ﹤0.01%
3,411
+958
+39% +$237K
COIN icon
820
Coinbase
COIN
$44.2B
$761K ﹤0.01%
3,017
+96
+3% +$27.9K
EXE
821
Expand Energy Corp
EXE
$21.2B
$752K ﹤0.01%
11,661
-5,867
-33% -$372K
LGV.U
822
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$751K ﹤0.01%
75,000
SBII.U
823
DELISTED
Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
SBII.U
$746K ﹤0.01%
75,000
CHAA.U
824
DELISTED
Catcha Investment Corp Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
CHAA.U
$743K ﹤0.01%
75,000
FTEV.U
825
DELISTED
FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant
FTEV.U
$741K ﹤0.01%
75,000

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.